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a  r  t  i  c  l  e  i  n  f  oArticle history:
Available online 1 October 2014Adult patients undergoing hematopoietic cell transplantation
(HCT) vary widely in terms of their requirement for nutrition
intervention and assessment of nutrient needs. Multiple fac-
tors throughout the HCT process impact nutritional status and
the need for nutrition intervention such as type of condition-
ing regimen, degree of regimen-related toxicity, infection and
graft-versus-host disease (GVHD).
As demonstrated in the study by Ferreira et al. entitled
“Nutritional status of patients submitted to transplantation
of allogeneic hematopoietic stem cells: a retrospective study”,
nutrition status is adversely affected early post-HCT by high-
dose conditioning regimens requiring hospitalization and
parenteral nutrition (PN) support.1 However, regardless of the
patient’s early post-HCT toxicities, their nutrition status can
also be drastically affected by later complications such as
acute/chronic GVHD and/or cytomegalovirus (CMV) enteritis.
Long-term complications resulting from immunosuppressive
medications such as steroid-induced diabetes mellitus, osteo-
porosis, hyperlipidemia and metabolic syndrome can also
affect nutrition status for months to years after HCT.
DOI of original article: http://dx.doi.org/10.1016/j.bjhh.2014.06.001.
 See paper by Ferreira et al. on pages 420–3.
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reserved.We  recommend an initial nutrition assessment by a reg-
istered dietitian for all patients undergoing allogeneic HCT
due to the anticipated nutrition issues associated with the
conditioning regimen. Ideally, the initial nutrition assess-
ment occurs prior to starting the conditioning regimen
and includes anthropometrics, laboratory data, diet com-
position/preferences, oral/gastrointestinal symptoms and
comorbidities. If a patient is identiﬁed as high nutrition risk
pre-HCT, intensive diet counseling and/or nutrition support
may be recommended in the pre-HCT time frame in order to
maximize nutrition status at time of hospital admission. Addi-
tionally, serial nutrition assessment is necessary to address
post-HCT complications that alter nutrient intake, absorption,
and utilization.2
Parenteral nutrition is not uniformly indicated for all
patients with less use among reduced-intensity and non-
myeloablative patients.3–7 Length of time on PN in this studynited States.
may be inﬂuenced by the fact that the majority of patients
received bone marrow infusion vs. peripheral blood stem cell
infusion which is associated with shorter engraftment and
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ecreased days of parenteral nutrition support.8 Close moni-
oring by a nutrition support team, including a dietitian, helps
revent overfeeding and minimizes hyperglycemia particu-
arly while a patient may still be meeting a percentage of their
alorie needs orally. The dietitian can also determine appro-
riate timing to discontinue PN thereby minimizing length of
ays on nutrition support and cost.9 As regimen-related toxi-
ities resolve, it is important to stress tolerable foods such as
ow ﬁber, and soft or pureed foods to increase calorie-protein
ntake and allow safe discontinuation of PN. PN can be safely
iscontinued once patients meet 30% of estimated needs with-
ut signs of malabsorption.10,11
Controversy exists regarding “neutropenic diet pre-
autions”. Many  hospitals continue to restrict fresh
ruits/vegetables, yogurts, spices and herbs despite the
act that studies have shown that strict “neutropenic diets”
o not decrease infection rates.2,12,13 Greater availability of
hese foods may, in fact, improve ﬂavor, palatability and
olerance as oral and gastrointestinal symptoms resolve
llowing expedited calorie-protein intake.
With later onset GVHD, whether acute or chronic, nutrition
ounseling is important to help patients make food choices for
est tolerance and symptom management while still meeting
alorie-protein goals to preserve lean body mass. Often diet
nd/or texture modiﬁcation are required for oral and gastroin-
estinal GVHD. In some cases, particularly with chronic GVHD,
nteral nutrition may be the best option to meet calorie-
rotein goals whenever feasible. Enteral nutrition is more  cost
ffective and maintains mucosal integrity with lower risk of
nfection.14,15
We  agree that nutrition status is compromised in allo-
eneic HCT patients during their hospital stay. However, for
ll allogeneic HCT patients, it is important to consider that
heir lifelong nutrition status may continue to be inﬂuenced
y sequelae resulting from HCT.
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